Active Ingredient Uptake

Bioavailability

Bioavailability describes the proportion of an active ingredient that reaches circulation and becomes available for the body to use.

Core Concept

What does it mean?

An ingredient may contain the correct labeled potency but still perform inefficiently if it dissolves poorly, breaks down during digestion, or is not absorbed effectively.

The Challenge

Poor solubility can reduce active availability

Many oil-soluble compounds do not mix well with digestive fluids. This can limit dissolution and create inconsistent absorption.

The Nano Approach

Nano delivery can improve active dispersion

Smaller delivery structures create greater surface area and may help active ingredients disperse more effectively in digestive environments.

Key Principles

How delivery science affects finished-product performance

Dispersion

Smaller delivery structures can distribute more evenly throughout compatible liquid and solid formulations.

Surface Area

Reducing particle size increases the available surface area of the active delivery system.

Uniformity

Controlled particle distribution supports consistent active concentration across the finished batch.

Stability

Properly designed delivery systems can help reduce settling, separation, and inconsistent product appearance.

Measurement Matters

Nano performance should be supported by data

Particle size, distribution, stability, potency, and application performance should be evaluated using appropriate technical testing rather than relying only on marketing terminology.

nm Particle size measurement
PDI Particle distribution uniformity
COA Potency and batch documentation
Stability Finished-product performance
Technical Support

Need help selecting a delivery system?

Speak with our team about particle size, formulation compatibility, nano powders, liquid delivery systems, samples, and technical documentation.